Formation of the embryonic-abembryonic axis of the mouse blastocyst: relationships between orientation of early cleavage divisions and pattern of symmetric/asymmetric divisions
Abstract
Setting aside pluripotent cells that give rise to the future body is a central cell fate decision in mammalian development. It requires that some blastomeres divide asymmetrically to direct cells to the inside of the embryo. Despite its importance, it is unknown whether the decision to divide symmetrically versus asymmetrically shows any spatial or temporal pattern, whether it is lineage-dependent or occurs at random, or whether it influences the orientation of the embryonic-abembryonic axis. To address these questions, we developed time-lapse microscopy to enable a complete 3D analysis of the origins, fates and divisions of all cells from the 2- to 32-cell blastocyst stage. This showed how in the majority of embryos, individual blastomeres give rise to distinct blastocyst regions. Tracking the division orientation of all cells revealed a spatial and temporal relationship between symmetric and asymmetric divisions and how this contributes to the generation of inside and outside cells and thus embryo patterning. We found that the blastocyst cavity, defining the abembryonic pole, forms where symmetric divisions predominate. Tracking cell ancestry indicated that the pattern of symmetric/asymmetric divisions of a blastomere can be influenced by its origin in relation to the animal-vegetal axis of the zygote. Thus, it appears that the orientation of the embryonic-abembryonic axis is anticipated by earlier cell division patterns. Together, our results suggest that two steps influence the allocation of cells to the blastocyst. The first step, involving orientation of 2- to 4-cell divisions along the animal-vegetal axis, can affect the second step, the establishment of inside and outside cell populations by asymmetric 8- to 32-cell divisions.
Additional Information
© 2008 the Author(s). Accepted 12 December 2007. We are grateful to Martin Johnson, David Glover, Chris Graham, Peter Lawrence and Jonathon Pines for comments and to Kat Hadjantonakis and Ginny Papaioannou for the EGFP-H2B transgenic line. The work was supported by a Wellcome Trust grant to M.Z.-G.; M.B. is supported by the MRC UK, the DFG, Germany and by a Wellcome Trust grant to Peter Lawrence to whom we are grateful for supporting M.B.'s contribution; D.-E.P. receives an MRC PhD studentship; M.Z.-G. is a Wellcome Trust Senior Research Fellow.Attached Files
Published - 953.full.pdf
Supplemental Material - 014316-figsS1-11.pdf
Supplemental Material - 014316-movie1.mov
Supplemental Material - 014316-movie2.mov
Supplemental Material - DEV01431-TableS1.pdf
Files
Name | Size | Download all |
---|---|---|
md5:050ea415f64b298e242134a234e42ec9
|
429.6 kB | Download |
md5:afe52e201054bf457c412da80b055bf1
|
607.0 kB | Download |
md5:19134297b38b0e0cbcf92e060d2fc792
|
809.1 kB | Preview Download |
md5:fdf8d057b51029fe017ce891289ab5e8
|
31.7 kB | Preview Download |
md5:edff4f64a21c2086489244e874e6f7e3
|
903.7 kB | Preview Download |
Additional details
- PMCID
- PMC2655627
- Eprint ID
- 94798
- Resolver ID
- CaltechAUTHORS:20190418-150055693
- Wellcome Trust
- Medical Research Council (UK)
- Deutsche Forschungsgemeinschaft (DFG)
- Created
-
2019-04-23Created from EPrint's datestamp field
- Updated
-
2021-11-16Created from EPrint's last_modified field